GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (OTCPK:BGLAF) » Definitions » ROC (Joel Greenblatt) %

BGLAF (BioGaia AB) ROC (Joel Greenblatt) % : 49.08% (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is BioGaia AB ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. BioGaia AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 49.08%.

The historical rank and industry rank for BioGaia AB's ROC (Joel Greenblatt) % or its related term are showing as below:

BGLAF' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 91.12   Med: 141.13   Max: 214.61
Current: 111.92

During the past 13 years, BioGaia AB's highest ROC (Joel Greenblatt) % was 214.61%. The lowest was 91.12%. And the median was 141.13%.

BGLAF's ROC (Joel Greenblatt) % is ranked better than
95.01% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 9.38 vs BGLAF: 111.92

BioGaia AB's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -3.20% per year.


BioGaia AB ROC (Joel Greenblatt) % Historical Data

The historical data trend for BioGaia AB's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGaia AB ROC (Joel Greenblatt) % Chart

BioGaia AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 121.78 96.59 90.54 144.40 149.88

BioGaia AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 150.63 102.10 162.88 136.97 49.08

Competitive Comparison of BioGaia AB's ROC (Joel Greenblatt) %

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioGaia AB's ROC (Joel Greenblatt) % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where BioGaia AB's ROC (Joel Greenblatt) % falls into.



BioGaia AB ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 40.03) - (0 + 0 + 20.979)
=19.051

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 37.335) - (0 + 0 + 18.806)
=18.529

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of BioGaia AB for the quarter that ended in Sep. 2024 can be restated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=19.268/( ( (20.42 + max(19.051, 0)) + (20.52 + max(18.529, 0)) )/ 2 )
=19.268/( ( 39.471 + 39.049 )/ 2 )
=19.268/39.26
=49.08 %

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioGaia AB  (OTCPK:BGLAF) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


BioGaia AB ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of BioGaia AB's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioGaia AB Business Description

Traded in Other Exchanges
Address
Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.

BioGaia AB Headlines

From GuruFocus

Q4 2020 Biogaia AB Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q1 2019 Biogaia AB Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q2 2021 Biogaia AB Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q2 2020 Biogaia AB Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q3 2024 Biogaia AB Earnings Call Transcript

By GuruFocus News 10-23-2024

Q4 2023 Biogaia AB Earnings Call Transcript

By GuruFocus Research 02-10-2024

Q3 2023 Biogaia AB Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q1 2020 Biogaia AB Earnings Call Transcript

By GuruFocus Research 02-12-2024